FGF23 and secondary hyperparathyroidism: CKD-mineral bone disorder (CKD-MBD) is characterized by abnormalities of bone and mineral metabolism and bone fragility together with increased FGF23, and secondary hyperparathyroidism in CKD patients on dialysis [1].